Holen Sie sich die Stockscreener-App
12.62
1.49%
-0.13
Schlusskurs vom Vortag:
$12.75
Offen:
$12.74
24-Stunden-Volumen:
24,444
Relative Volume:
0.22
Marktkapitalisierung:
$213.98M
Einnahmen:
$6.67M
Nettoeinkommen (Verlust:
$-47.55M
KGV:
-8.4133
EPS:
-1.5
Netto-Cashflow:
$-17.44M
1W Leistung:
-3.38%
1M Leistung:
+7.17%
6M Leistung:
+2,356%
1J Leistung:
+2,356%
1-Tages-Spanne:
$12.42
$12.74
1-Wochen-Bereich:
$12.30
$13.27
52-Wochen-Spanne:
$9.81
$21.40
Crescent Biopharma Inc Stock (CBIO) Company Profile
Firmenname
Crescent Biopharma Inc
Sektor
Branche
Telefon
617-430-5595
Adresse
300 FIFTH AVENUE, WALTHAM, CA
Vergleichen Sie CBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBIO
Crescent Biopharma Inc
|
12.51 | 213.98M | 6.67M | -47.55M | -17.44M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.98 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.86 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.60 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
819.59 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
180.28 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | Jefferies | Buy |
| 2025-08-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-14 | Eingeleitet | Wedbush | Outperform |
| 2025-06-25 | Eingeleitet | Stifel | Buy |
| 2025-03-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-03-11 | Eingeleitet | Noble Capital Markets | Outperform |
| 2024-07-26 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-22 | Eingeleitet | CapitalOne | Overweight |
| 2021-11-12 | Hochstufung | Jefferies | Hold → Buy |
| 2021-04-29 | Fortgesetzt | Stephens | Overweight |
| 2021-02-10 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-21 | Eingeleitet | Raymond James | Outperform |
| 2019-11-14 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-08-05 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-01-04 | Eingeleitet | Oppenheimer | Outperform |
| 2018-12-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-02-12 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Eingeleitet | Chardan Capital Markets | Buy |
| 2017-06-06 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-07-26 | Eingeleitet | SunTrust | Buy |
| 2016-06-30 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-17 | Bestätigt | Stifel | Buy |
Alle ansehen
Crescent Biopharma Inc Aktie (CBIO) Neueste Nachrichten
What valuation ratios show for Crescent Biopharma Inc. (GKO0) stockM&A Rumor & AI Enhanced Market Trend Forecasts - newser.com
Crescent BiopharmaLighting The Path To The Next Wave Of Cancer Therapies? - RTTNews
What market sentiment indicators show for Crescent Biopharma Inc. (GKO0) stockTrade Analysis Summary & Safe Capital Growth Tips - newser.com
Is Crescent Biopharma Inc. (GKO0) stock a top hedge fund pickTrade Volume Summary & Verified Swing Trading Watchlist - newser.com
Is Crescent Biopharma Inc. (GKO0) stock expanding market penetration2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Will Crescent Biopharma Inc. (GKO0) stock top growth indexes2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Retail Surge: Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Price Swings & Reliable Price Breakout Alerts - Trung tâm Dự báo KTTV quốc gia
Moving Averages: Can Crescent Biopharma Inc. (GKO0) stock stage a strong rebound this quarter2025 Performance Recap & Stepwise Trade Signal Implementation - Trung tâm Dự báo KTTV quốc gia
TANG CAPITAL MANAGEMENT LLC Increases Stake in Crescent Biopharm - GuruFocus
GlycoMimetics skyrockets on buyout deal - MSN
Crescent Biopharma (NASDAQ:CBIO) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
GlycoMimetics adjusts merger terms with Crescent Biopharma - MSN
Will Crescent Biopharma Inc. (GKO0) stock benefit from Fed rate cutsJuly 2025 Update & Safe Entry Zone Identification - newser.com
Short Interest in Crescent Biopharma, Inc. (NASDAQ:CBIO) Grows By 103.8% - MarketBeat
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives $25.60 Consensus Target Price from Analysts - Defense World
Will Crescent Biopharma Inc. (GKO0) stock hit Wall Street targetsJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Finanzdaten der Crescent Biopharma Inc-Aktie (CBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):